We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Human T Cell and Antibody-Mediated Responses to the Mycobacterium tuberculosis Recombinant 85A, 85B, and ESAT-6 Antigens

Read time: Less than a minute

Tuberculosis remains a major health problem throughout the world causing large number of deaths. Effective disease control and eradication programs require the identification of major antigens recognized by the protective responses against M. tuberculosis.

The work reported within this article demonstrates how Ag85A and ESAT-6 are antigens able to differentiate pulmonary, extra-pulmonary and tuberculosis patients undergoing chemotherapy from healthy individuals by IFN- γ production and pulmonary and under treatment patients from extra-pulmonary TB by TNF-α. Therefore, not only IFN-γ production but also TNF-α to Ag85A and ESAT-6 could be used as biomarkers for the clinical status of TB patients while IL-10 could be useful monitoring TB successful treatment.

The article is published online within the journal, Clinical and Developmental Immunology and is free to access.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.